Azathioprine
Showing 26 - 50 of 606
Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis Trial in Saint Louis (Baricitinib 2 MG [Olumiant], Methotrexate,
Recruiting
- Mucous Membrane Pemphigoid
- Cicatrizing Conjunctivitis
- Baricitinib 2 MG [Olumiant]
- +3 more
-
Saint Louis, MissouriBarnes Jewish Hospital / Washington University in St. Louis
Feb 21, 2022
ANCA Associated Vasculitis, Maintenance Therapy Trial in China (Leflunomide, Azathioprine Tablets)
Recruiting
- ANCA Associated Vasculitis
- Maintenance Therapy
- Leflunomide
- Azathioprine Tablets
-
Hefei, Anhui, China
- +3 more
Nov 26, 2021
Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)
Recruiting
- Inflammatory Disease
- +2 more
- Infliximab subcutaneous
- Immunosuppressive Agents
-
Amsterdam, North Holland, NetherlandsAmsterdam UMC AMC
Sep 27, 2023
Antisynthetase Syndrome (ASS), Interstitial Lung Disease Trial in Paris (Cyclophosphamide and azathioprine, Tacrolimus)
Recruiting
- Antisynthetase Syndrome (ASS)
- Interstitial Lung Disease
- Cyclophosphamide and azathioprine
- Tacrolimus
-
Paris, FranceHôpital Universitaire Pitié Salpêtrière
Feb 6, 2021
Ulcerative Colitis Trial in France (Azathioprine, Infliximab, Prednisolone)
Recruiting
- Ulcerative Colitis
- Azathioprine
- +3 more
-
Besancon, France
- +15 more
Jan 19, 2021
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
Post-Operative Crohn's Disease Outcome in Children
Recruiting
- Crohn Disease
- Azathioprine
- Anti-TNF Drug
-
Petach Tikva, IsraelSchneider Children's Hospital
Sep 25, 2021
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)
Completed
- Neuromyelitis Optica Spectrum Disorder
- Azathioprine
- Rituximab
-
Isfahan, Iran, Islamic Republic ofKashani Hospital
Sep 29, 2020
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Recruiting
- Myasthenia Gravis
- Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
-
Beijing, Beijing, ChinaXuan Wu Hospital, Capital Medical University
Aug 19, 2021
Pancreatitis, IBD Trial in Jerusalem (Azathioprine)
Withdrawn
- Pancreatitis
- Inflammatory Bowel Diseases
- Azathioprine
-
Jerusalem, IsraelShaare Zedek
Mar 17, 2021
Nephritis of Lupus Trial in Marseille (mycophenolate mofetil or azathioprine, immunosuppressive treatment discontinuation)
Active, not recruiting
- Nephritis of Lupus
- mycophenolate mofetil or azathioprine
- immunosuppressive treatment discontinuation
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Feb 25, 2021
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide
Completed
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- +2 more
- Rituximab
- Azathioprine
-
Los Angeles, California
- +37 more
Feb 18, 2022
IBD, Crohn Disease, Polyunsaturated Acid Lipidosis Trial (azathioprine, infliximab, N-3 Polyunsaturated Fatty Acids)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- azathioprine
- +2 more
- (no location specified)
Feb 18, 2021
End-Stage Renal Disease Trial in Vancouver (Conversion to Advagraf, conversion of non-immunosuppressant drugs to once daily,
Active, not recruiting
- End-Stage Renal Disease
- Conversion to Advagraf
- +2 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2021
Systemic Lupus Erythematosus (SLE) Trial in United States (Anifrolumab, Standard of Care)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- Anifrolumab
- Standard of Care
-
New Haven, Connecticut
- +4 more
Nov 18, 2021
Ulcerative Colitis Trial in Shandong (Prednisone, Azathioprine, Adalimumab)
Recruiting
- Ulcerative Colitis
- Prednisone
- +3 more
-
Shandong, Shandong, ChinaThe Second Affiliated Hospital of Shandong University of Traditi
May 11, 2021
Crohn's Disease Trial in Lucknow (Artesunate, Curcumin, Placebo A)
Not yet recruiting
- Crohn's Disease
- Artesunate
- +3 more
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIM
Jan 20, 2021
Gout Trial in United States (Pegloticase, Azathioprine)
Completed
- Gout
- Pegloticase
- Azathioprine
-
Birmingham, Alabama
- +10 more
Oct 7, 2021
Transplantation, Liver Trial in London, Newcastle (Biomarker, Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate
Active, not recruiting
- Transplantation, Liver
- Biomarker
- Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine
-
London, United Kingdom
- +1 more
Mar 10, 2021
Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa, IgA Vasculitis Trial in Canada, Japan, United States (Colchicine,
Recruiting
- Primary Cutaneous Vasculitis
- +3 more
- Colchicine
- +2 more
-
Kansas City, Kansas
- +12 more
Jan 25, 2022